NCT06881420

Brief Summary

This study will explore the safety and efficacy of BASIS technology in ICAS-LVO lesions through a multicenter, prospective, registry, observational single-arm study.By registering intraoperative recanalization using this technique time, recanalization grade, operative thrombectomy times, intraoperative complications perforating branch occlusion, vascular dissection, vascular rupture, Ectopic thrombus, probability of symptomatic intracranial hemorrhage, mRS Score and mortality rate were followed up for 3 months The unique advantages of the application of the assessment BASIS in this type of lesion provide new insights into complex lesions such as ICAS-LVO The thought and operation method can shorten the operation time, improve the good prognosis, reduce the economic burden and reduce the operation Complications make a positive contribution to ensure that patients receive safe, effective and precise treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 18, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 18, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

January 19, 2025

Last Update Submit

March 11, 2025

Conditions

Keywords

Acute Ischemic StrokeICAS - Intracranial AtherosclerosisEndovascular thrombectomyBASIS

Outcome Measures

Primary Outcomes (2)

  • mRS scores at 90 days

    functional recovery, assessed by change in modified Rankin Scale (mRS) scores (ranging from 0 \[no symptoms\] to 6 \[death\]) at 90 days after onset

    90 days

  • FPE:first pass effect

    Vascular revascularization rate by basis technique at the first attempt

    From enrollment to the end of the surgery about 3 hours

Secondary Outcomes (1)

  • Residual stenosis rate of target vessel

    From enrollment to the end of the surgery about 3 hours

Study Arms (1)

using BASIS technique

Procedure: BASIS technique

Interventions

Balloon AngioplaSty with the dIstal protection of Stent retriever

using BASIS technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ICAS-LAO stroke

You may qualify if:

  • Age ≥18 years old;
  • Ischemic stroke;
  • Within 72 hours from the onset of symptoms to the time of visit, including post-awakening stroke or blindness For stroke patients, the time when symptoms start is defined as "the last normal time";
  • Neuroimaging examination indicated occlusion of anterior or posterior intracranial large vessels, TOAST type was large atherosclerosis type.
  • BASIS technique was used for intravascular therapy.

You may not qualify if:

  • Neuroimaging findings on admission, acute occlusion of multiple vessels and tandem lesions;
  • History of atrial fibrillation or heart valve surgery;
  • There are clinical contraindications to the use of antiplatelet drugs (hemophilia or thrombocytopenia).Rare disease, known history of coagulation disorders, platelet abnormalities; There is active internal bleeding, intracranial Bleeding history, arteriovenous malformation, aneurysm, etc.);
  • Other types of stroke, including hemorrhagic stroke.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeIntracranial Arteriosclerosis

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesIntracranial Arterial DiseasesArteriosclerosisArterial Occlusive Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2025

First Posted

March 18, 2025

Study Start

January 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 18, 2025

Record last verified: 2025-01

Locations